Novartis
NVS
NVS
1,086 hedge funds and large institutions have $23.4B invested in Novartis in 2018 Q4 according to their latest regulatory filings, with 143 funds opening new positions, 341 increasing their positions, 403 reducing their positions, and 76 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
4% more capital invested
Capital invested by funds: $22.4B → $23.4B (+$988M)
0.53% more ownership
Funds ownership: 11.4% → 11.93% (+0.53%)
15% less repeat investments, than reductions
Existing positions increased: 341 | Existing positions reduced: 403
Holders
1,086
Holding in Top 10
40
Calls
$108M
Puts
$80.5M
Top Buyers
| 1 | +$678M | |
| 2 | +$491M | |
| 3 | +$156M | |
| 4 |
Mawer Investment Management
Calgary,
Alberta, Canada
|
+$142M |
| 5 |
Boston Partners
Boston,
Massachusetts
|
+$125M |
Top Sellers
| 1 | -$649M | |
| 2 | -$379M | |
| 3 | -$88.8M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$78.7M |
| 5 |
Millennium Management
New York
|
-$72.4M |